Ajinomoto Bio-Pharma Services

Global CDMO with facilities in Belgium, USA (Grove City, OH), Japan, and India. Offers small molecule manufacturing, oligo & peptide synthesis (solid phase + AJIPHASE liquid phase), ADC services, HPAPI, large molecule manufacturing, and gene therapy. Services span preclinical through commercial cGMP production.

Ajinomoto Bio-Pharma Services is listed as a CDMO in the peptide supply chain, serving North America markets from USA (Grove City, OH) / Belgium / Japan / India. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.